Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 4, Status: Authorised
Pool of patient and consumer experts: list for 2024-2029
Pool of healthcare professional experts: list for 2024-2029
Veterinary medicines European public assessment report (EPAR): Respiporc Flu3, inactivated influenza-A virus, Status: Authorised
Veterinary medicines European public assessment report (EPAR): ReproCyc ParvoFLEX, porcine parvovirosis vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Reconcile, fluoxetine, Status: Authorised
Template for scientific document for paediatric investigation plan or product-specific waiver
Veterinary medicines European public assessment report (EPAR): ProZinc, insulin human, Status: Authorised
Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 10, Status: Withdrawn
Veterinary medicines European public assessment report (EPAR): Profender, emodepside,praziquantel, Status: Authorised